Mayrin Correa Medina
Overview
Explore the profile of Mayrin Correa Medina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonta R, Schenkel J, Klein K, Martinez F, Medina M
Transfus Med
. 2024 Nov;
PMID: 39601217
Background: Granulocyte transfusions represent a therapeutic option for severely neutropenic patients with bacterial or fungal infections that are otherwise unresponsive to conventional therapy. Prior clinical studies suggest that patients receiving...
2.
Park N, Medina M, Martinez F, Throssel M, Dasgupta A, Knopfelmacher A, et al.
Lab Med
. 2024 Jan;
55(3):251-254.
PMID: 38175635
Background: Due to chemotherapy-induced neutropenia or hematologic malignancies, immunocompromised cancer patients may have higher incidence of febrile nonhemolytic transfusion reactions compared with the general population and frequently require platelet transfusions....
3.
Villamin C, Bates T, Mescher B, Benitez S, Martinez F, Knopfelmacher A, et al.
Transfusion
. 2022 Apr;
62(5):1010-1018.
PMID: 35442519
Background: Transfusion carries a risk of transfusion reaction that is often underdiagnosed due to reliance on passive reporting. The study investigated the utility of digital methods to identify potential transfusion...
4.
Maldonado M, Villamin C, Murphy L, Dasgupta A, Bassett R, Medina M, et al.
Lab Med
. 2022 Mar;
53(4):344-348.
PMID: 35285900
Background: Transfusion-associated circulatory overload (TACO) is a largely preventable transfusion complication that results in significant morbidity and mortality. Cancers, related treatments, and comorbidities are among the factors that can predispose...
5.
Rajbhandary S, Andrzejewski C, Fridey J, Stotler B, Tsang H, Hindawi S, et al.
Transfusion
. 2022 Jan;
62(3):540-545.
PMID: 35044688
Background: Under-transfusion is an underreported entity within most hospitals and hemovigilance systems. While critical blood shortages are being reported more frequently, without incident codes to document instances of under-transfusion due...
6.
Greenbaum U, Klein K, Martinez F, Song J, Thall P, Ramdial J, et al.
Front Immunol
. 2021 May;
12:675679.
PMID: 33995420
Background: COVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific...
7.
Greenbaum U, Klein K, Martinez F, Song J, Thall P, Ramdial J, et al.
medRxiv
. 2021 Mar;
PMID: 33758890
Background: COVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific...
8.
Pastar I, Khan A, Stojadinovic O, Lebrun E, Medina M, Brem H, et al.
J Biol Chem
. 2012 Jul;
287(35):29324-35.
PMID: 22773832
Chronic nonhealing wounds, such as venous ulcers (VUs), are a widespread and serious medical problem with high morbidity and mortality. The molecular pathology of VUs remains poorly understood, impeding the...